Skip to main content
Log in

Loss of PPARα perpetuates sex differences in stroke reflected by peripheral immune mechanisms

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Peroxisome proliferator-activated receptor alpha (PPARα) is a nuclear receptor transcription factor that plays a role in immune regulation. Because of its expression in cerebral tissue and immune cells, PPARα has been examined as an important regulator in immune-based neurological diseases. Many studies have indicated that pre-treatment of animals with PPARα agonists induces protection against stroke. However, our previous reports indicate that protection is only in males, not females, and can be attributed to different PPARα expression between the sexes. In the current study, we examine how loss of PPARα affects male and female mice in experimental stroke. Male and female PPARα knockout mice were subject to middle cerebral artery occlusion (MCAO) or sham surgery, and the ischemic (local) or spleen specific (peripheral) immune response was examined 96 h after reperfusion. We found that loss of PPARα perpetuated sex differences in stroke, and this was driven by the peripheral, not local, immune response. Specifically we observed an increase in peripheral pro-inflammatory and adhesion molecule gene expression in PPARα KO males after MCAO compared to females. Our data supports previous evidence that PPARα plays an important role in sex differences in the immune response to disease, including stroke.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

PPARα:

Peroxisome proliferator-activated receptor alpha

MCAO:

Middle cerebral artery occlusion

Treg:

Regulatory T cell

References

  • Banerjee A, Wang J, Bodhankar S, Vandenbark AA, Murphy SJ, Offner H (2013) Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs. female mice. Transl Stroke Res 4:554–563. doi:10.1007/s12975-013-0268-z

    Article  CAS  PubMed  Google Scholar 

  • Bishop-Bailey D (2000) Peroxisome proliferator-activated receptors in the cardiovascular system. Br J Pharmacol 129:823–834. doi:10.1038/sj.bjp.0703149

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, −beta, and -gamma in the adult rat. Endocrinology 137:354–366. doi:10.1210/endo.137.1.8536636

    CAS  PubMed  Google Scholar 

  • Chinetti G et al (1998) Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages. J Biol Chem 273:25573–25580

    Article  CAS  PubMed  Google Scholar 

  • Collino M et al (2006) Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643. Free Radic Biol Med 41:579–589. doi:10.1016/j.freeradbiomed.2006.04.030

    Article  CAS  PubMed  Google Scholar 

  • Cullingford TE, Bhakoo K, Peuchen S, Dolphin CT, Patel R, Clark JB (1998) Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system. J Neurochem 70:1366–1375

    Article  CAS  PubMed  Google Scholar 

  • Delerive P, Fruchart JC, Staels B (2001) Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169:453–459

    Article  CAS  PubMed  Google Scholar 

  • Deplanque D et al (2003) Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci Off J Soc Neurosc 23:6264–6271

    CAS  Google Scholar 

  • Di Carlo A et al (2003) Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 34:1114–1119. doi:10.1161/01.str.0000068410.07397.d7

    Article  PubMed  Google Scholar 

  • Dotson AL, Wang J, Chen Y, Manning D, Nguyen H, Saugstad JA, Offner H (2015a) Sex differences and the role of PPAR alpha in experimental stroke. Metab Brain Dis. doi:10.1007/s11011-015-9766-x

    PubMed  Google Scholar 

  • Dotson AL, Wang J, Saugstad J, Murphy SJ, Offner H (2015b) Splenectomy reduces infarct volume and neuroinflammation in male but not female mice in experimental stroke. J Neuroimmunol 278:289–298. doi:10.1016/j.jneuroim.2014.11.020

    Article  CAS  PubMed  Google Scholar 

  • Dunn SE et al (2007) Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity. J Exp Med 204:321–330. doi:10.1084/jem.20061839

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ginsberg HN et al (2010) Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 362:1563–1574. doi:10.1056/NEJMoa1001282

    Article  PubMed  Google Scholar 

  • Guo Q, Wang G, Namura S (2010) Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 30:70–78. doi:10.1038/jcbfm.2009.185

    Article  CAS  Google Scholar 

  • Hurn PD, Subramanian S, Parker SM, Afentoulis ME, Kaler LJ, Vandenbark AA, Offner H (2007) T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 27:1798–1805. doi:10.1038/sj.jcbfm.9600482

    Article  CAS  Google Scholar 

  • Jalouli M et al (2003) Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones. Endocrinology 144:101–109. doi:10.1210/en.2002-220630

    Article  CAS  PubMed  Google Scholar 

  • Jones DC, Ding X, Daynes RA (2002) Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent. J Biol Chem 277:6838–6845. doi:10.1074/jbc.M106908200

    Article  CAS  PubMed  Google Scholar 

  • Kainu T, Wikstrom AC, Gustafsson JA, Pelto-Huikko M (1994) Localization of the peroxisome proliferator-activated receptor in the brain. Neuroreport 5:2481–2485

    Article  CAS  PubMed  Google Scholar 

  • Leuenberger N, Pradervand S, Wahli W (2009) Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice. J Clin Invest 119:3138–3148. doi:10.1172/jci39019

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Losey P, Ladds E, Laprais M, Geuvel B, Burns L, Bordet R, Anthony DC (2015) The role of PPAR activation during the systemic response to brain injury. J Neuroinflammation 12:99. doi:10.1186/s12974-015-0295-7

    Article  PubMed  PubMed Central  Google Scholar 

  • Marx N, Sukhova GK, Collins T, Libby P, Plutzky J (1999) PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 99:3125–3131

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Moreno S, Farioli-Vecchioli S, Ceru MP (2004) Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123:131–145

    Article  CAS  PubMed  Google Scholar 

  • Mozaffarian D et al (2015) Heart disease and stroke statistics--2015 update: a report from the american heart association. Circulation 131:e29–e322. doi:10.1161/cir.0000000000000152

    Article  PubMed  Google Scholar 

  • Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD (2006a) Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 26:654–665. doi:10.1038/sj.jcbfm.9600217

    Article  CAS  Google Scholar 

  • Offner H et al (2006b) Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol (Baltimore, Md : 1950) 176:6523–6531

    Article  CAS  Google Scholar 

  • Ouk T et al (2014) Effects of the PPAR-alpha agonist fenofibrate on acute and short-term consequences of brain ischemia. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 34:542–551. doi:10.1038/jcbfm.2013.233

    Article  CAS  Google Scholar 

  • Poynter ME, Daynes RA (1998) Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 273:32833–32841

    Article  CAS  PubMed  Google Scholar 

  • Seifert HA, Hall AA, Chapman CB, Collier LA, Willing AE, Pennypacker KR (2012a) A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation. J NeuroImmune Pharmacol 7:1017–1024. doi:10.1007/s11481-012-9406-8

    Article  PubMed  PubMed Central  Google Scholar 

  • Seifert HA et al (2012b) The spleen contributes to stroke induced neurodegeneration through interferon gamma signaling. Metab Brain Dis 27:131–141. doi:10.1007/s11011-012-9283-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Trottier J, Caron P, Straka RJ, Barbier O (2011) Profile of serum bile acids in noncholestatic volunteers: gender-related differences in response to fenofibrate. Clin Pharmacol Ther 90:279–286. doi:10.1038/clpt.2011.124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Turner RC, Lucke-Wold B, Lucke-Wold N, Elliott AS, Logsdon AF, Rosen CL, Huber JD (2013) Neuroprotection for ischemic stroke: moving past shortcomings and identifying promising directions. Int J Mol Sci 14:1890–1917. doi:10.3390/ijms14011890

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wege N et al (2015) Men and women differ in their diurnal expression of monocyte peroxisome proliferator-activated receptor-alpha in the fed but not in the fasted state. FASEB J Off Publ Fed Am Soc Exp Biol 29:2905–2911. doi:10.1096/fj.14-267575

    CAS  Google Scholar 

  • Yessoufou A, Hichami A, Besnard P, Moutairou K, Khan NA (2006) Peroxisome proliferator-activated receptor alpha deficiency increases the risk of maternal abortion and neonatal mortality in murine pregnancy with or without diabetes mellitus: modulation of T cell differentiation. Endocrinology 147:4410–4418. doi:10.1210/en.2006-0067

    Article  CAS  PubMed  Google Scholar 

  • Zhang W et al (2008) Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia. Stroke 39:2073–2078. doi:10.1161/strokeaha.107.508325

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors wish to thank Gail Kent for assistance with manuscript submission. This work was supported by NIH/NINDS 5R01NS076013 (HO, JAS). This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The contents do not represent the views of the Department of Veterans Affairs or the United States Government.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Halina Offner.

Ethics declarations

Compliance with ethical standards

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of Oregon Health & Science University’s Institutional Animal Care and Use Committee.

This article does not contain any studies with human participants performed by any of the authors.

Funding

This work was supported by NIH/NINDS 5R01NS076013 (HO, JAS). This material is based upon work supported in part by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. The contents do not represent the views of the Department of Veterans Affairs or the United States Government.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dotson, A.L., Wang, J., Liang, J. et al. Loss of PPARα perpetuates sex differences in stroke reflected by peripheral immune mechanisms. Metab Brain Dis 31, 683–692 (2016). https://doi.org/10.1007/s11011-016-9805-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-016-9805-2

Keywords

Navigation